Lilly-partnered AbCellera gets COVID-19 boost from Canadian government

After penning a deal with Eli Lilly last month with the aim to have an antibody in the clinic within four months, Canadian-based AbCellera has been given a financial boost by its government.

AbCellera said it will get up to $175.6 million in support from the government of Canada under its so-called Innovation, Science and Economic Development Canada Strategic Innovation Fund.